Whitehawk Therapeutics, Inc. (WHWK) stock
WHWKNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.13+0.05 (+1.62%)
Close on Nov 18, 2026Market cap $178.44MP/E –Yield –
Whitehawk Therapeutics total assets
Total assets on the balance sheet at the end of each period.
Whitehawk Therapeutics's total assets was $193.99M at Jun 30, 2026. For fiscal 2025 it was $150.83M, up 114.5% from the year before. Over ten years it grew 146.1% a year on average. The highest annual figure on record is $184.24M in fiscal 2022.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $150.83M | +114.5% |
| FY2024 | Dec 31, 2024 | $70.32M | -46.9% |
| FY2023 | Dec 31, 2023 | $132.42M | -28.1% |
| FY2022 | Dec 31, 2022 | $184.24M | +16.7% |
| FY2021 | Dec 31, 2021 | $157.91M | +738.8% |
| FY2020 | Dec 31, 2020 | $18.83M | -52.9% |
| FY2019 | Dec 31, 2019 | $39.94M | -37.7% |
| FY2018 | Dec 31, 2018 | $64.12M | +204.9% |
| FY2017 | Dec 31, 2017 | $21.03M | +777.3% |
| FY2016 | Dec 31, 2016 | $2.40M | +12835.8% |
| FY2015 | Dec 31, 2015 | $18.53K | +252.1% |
| FY2014 | Dec 31, 2014 | $5.26K | -40.1% |
| FY2013 | Dec 31, 2013 | $8.78K | +8.3% |
| FY2012 | Dec 31, 2012 | $8.11K | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $193.99M | +7.3% |
| Q1 FY2026 | Mar 31, 2026 | $127.23M | -45.6% |
| Q4 FY2025 | Dec 31, 2025 | $150.83M | +114.5% |
| Q3 FY2025 | Sep 30, 2025 | $167.02M | +94.9% |
| Q2 FY2025 | Jun 30, 2025 | $180.82M | +77.9% |
| Q1 FY2025 | Mar 31, 2025 | $234.00M | +110.7% |
| Q4 FY2024 | Dec 31, 2024 | $70.32M | -46.9% |
| Q3 FY2024 | Sep 30, 2024 | $85.70M | -38.6% |
| Q2 FY2024 | Jun 30, 2024 | $101.62M | -32.8% |
| Q1 FY2024 | Mar 31, 2024 | $111.07M | -34.9% |
| Q4 FY2023 | Dec 31, 2023 | $132.42M | -28.1% |
| Q3 FY2023 | Sep 30, 2023 | $139.66M | -28.0% |
| Q2 FY2023 | Jun 30, 2023 | $151.23M | +17.6% |
| Q1 FY2023 | Mar 31, 2023 | $170.65M | +19.9% |
| Q4 FY2022 | Dec 31, 2022 | $184.24M | +16.7% |
| Q3 FY2022 | Sep 30, 2022 | $194.10M | +15.0% |
| Q2 FY2022 | Jun 30, 2022 | $128.64M | +243.7% |
| Q1 FY2022 | Mar 31, 2022 | $142.32M | +245.8% |
| Q4 FY2021 | Dec 31, 2021 | $157.91M | +738.8% |
| Q3 FY2021 | Sep 30, 2021 | $168.77M | +238.7% |
| Q2 FY2021 | Jun 30, 2021 | $37.42M | -18.1% |
| Q1 FY2021 | Mar 31, 2021 | $41.16M | +15.3% |
| Q4 FY2020 | Dec 31, 2020 | $18.83M | -52.9% |
| Q3 FY2020 | Sep 30, 2020 | $49.83M | +9.4% |
| Q2 FY2020 | Jun 30, 2020 | $45.72M | -7.8% |
| Q1 FY2020 | Mar 31, 2020 | $35.70M | -35.2% |
| Q4 FY2019 | Dec 31, 2019 | $39.94M | -37.7% |
| Q3 FY2019 | Sep 30, 2019 | $45.55M | -35.1% |
| Q2 FY2019 | Jun 30, 2019 | $49.60M | -28.7% |
| Q1 FY2019 | Mar 31, 2019 | $55.06M | +273.7% |
| Q4 FY2018 | Dec 31, 2018 | $64.12M | +204.9% |
| Q3 FY2018 | Sep 30, 2018 | $70.16M | +169.8% |
| Q2 FY2018 | Jun 30, 2018 | $69.54M | +133.4% |
| Q1 FY2018 | Mar 31, 2018 | $14.73M | -59.4% |
| Q4 FY2017 | Dec 31, 2017 | $21.03M | +777.3% |
| Q3 FY2017 | Sep 30, 2017 | $26.00M | +331680.1% |
| Q2 FY2017 | Jun 30, 2017 | $29.79M | – |
| Q1 FY2017 | Mar 31, 2017 | $36.28M | – |
| Q4 FY2016 | Dec 31, 2016 | $2.40M | – |
| Q3 FY2016 | Sep 30, 2016 | $7.84K | – |
See a number that looks wrong?